Effect of Endocrine Therapies on Bone in Breast Cancer PatientsSANTEN, R. J.The Journal of clinical endocrinology and metabolism. 2011, Vol 96, Num 2, pp 308-319, issn 0021-972X, 12 p.Article

Clinical use of aromatase inhibitors : current data and future perspectivesSANTEN, R. J.Journal of enzyme inhibition. 1990, Vol 4, Num 2, pp 79-99, issn 8755-5093, 21 p.Article

Hormonal therapy of prostate cancer: choosing among several available optionsSANTEN, R. J.International journal of andrology (Print). 1989, Vol 12, Num 3, pp 165-170, issn 0105-6263Article

Proceeding. I/Aromatase: future perspectives, conference, Miami FL, March 4-7, 1987SANTEN, R. J.Steroids. 1987, Vol 50, Num 1-3, issn 0039-128X, 338 p.Conference Proceedings

Recent progress in development of aromatase inhibitorsSANTEN, R. J.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 1029-1035, issn 0960-0760, 7 p.Conference Paper

Estrogen synthesis inhibitors : from off the rack to haute coutureSANTEN, R. J; PUGH, E.The Journal of clinical endocrinology and metabolism. 1993, Vol 77, Num 2, pp 316-318, issn 0021-972XArticle

Evidence of In situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfataseMASAMURA, S; SANTNER, S. J; SANTEN, R. J et al.Journal of steroid biochemistry and molecular biology. 1996, Vol 58, Num 4, pp 425-429, issn 0960-0760Article

Ablative procedures in patients with metastatic breast carcinoma = Hormonothérapie suppressive dans les cancers métastatiques du seinWELLS, S. A; SANTEN, R. J.Cancer. 1984, Vol 53, Num 3, pp 762-765, issn 0008-543XArticle

Aromatase inhibitors : Rationale for use following antiestrogen therapyYUE, W; SANTEN, R. J.Seminars in oncology. 1996, Vol 23, Num 4, pp 21-27, issn 0093-7754, SUP9Article

Aromatase and its inhibitors in breast cancer treatment : overview and perspectiveBRODIE, A. M. H; SANTEN, R. J.Breast cancer research and treatment. 1994, Vol 30, Num 1, pp 1-6, issn 0167-6806Article

Suppression of residual oestrogen production with aminoglutethimide in women following surgical hypophysectomy or adrenalectomySAMOJLIK, E; SANTEN, R. J; WORGUL, T. J et al.Clinical endocrinology (Oxford. Print). 1984, Vol 20, Num 1, pp 43-51, issn 0300-0664Article

Apoptotic action of estrogenSONG, R. X.-D; SANTEN, R. J.Apoptosis (London). 2003, Vol 8, Num 1, pp 55-60, issn 1360-8185, 6 p.Article

Relative versus attributable risk of breast cancer from estrogen replacement therapySANTEN, R. J; PETRONI, G. R.The Journal of clinical endocrinology and metabolism. 1999, Vol 84, Num 6, pp 1875-1881, issn 0021-972XArticle

Statistical analysis of in vitro tumor growth experimentsHEITJAN, D. F; MANNI, A; SANTEN, R. J et al.Cancer research (Baltimore). 1993, Vol 53, Num 24, pp 6042-6050, issn 0008-5472Article

Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancerENGLISH, H. F; HEITJAN, D. F; LANCASTER, S et al.Cancer research (Baltimore). 1991, Vol 51, Num 7, pp 1760-1765, issn 0008-5472, 6 p.Article

Special article : androgens : risks and benefitsWAYNE BARDIN, C; SWERDLOFF, R. S; SANTEN, R. J et al.The Journal of clinical endocrinology and metabolism. 1991, Vol 73, Num 1, pp 4-7, issn 0021-972X, 4 p.Article

Clinical and biochemical parameters of androgen action in normal healthy caucasian versus Chinese subjectsLOOKINGBILL, D. P; DEMERS, L. M; WANG, C et al.The Journal of clinical endocrinology and metabolism. 1991, Vol 72, Num 6, pp 1242-1248, issn 0021-972XArticle

Interaction between parathyroid hormone and endogenous estrogen in normal womenBUCHANAN, J. R; SANTEN, R. J; CAVALIERE, A et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 6, pp 489-494, issn 0026-0495Article

Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with β-cell neoplasms of the pancreasBRUNT, L. M; VELDHUIS, J. D; DILLEY, W. G et al.The Journal of clinical endocrinology and metabolism. 1986, Vol 62, Num 1, pp 210-216, issn 0021-972XArticle

Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromataseSANTNER, S. J; ROSEN, H; OSAWA, Y et al.Journal of steroid biochemistry. 1984, Vol 20, Num 6A, pp 1239-1242, issn 0022-4731Article

Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress reportSASANO, H; EDWARDS, D. P; ANDERSON, T. J et al.Journal of steroid biochemistry and molecular biology. 2003, Vol 86, Num 3-5, pp 239-244, issn 0960-0760, 6 p.Conference Paper

Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinomaCOSTA, L. A. M; KOPRESKI, M. S; DEMERS, L. M et al.Cancer. 1999, Vol 85, Num 1, pp 100-103, issn 0008-543XArticle

Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the ratSINHA, S; KASETA, J; SANTNER, S. J et al.Breast cancer research and treatment. 1998, Vol 48, Num 1, pp 45-51, issn 0167-6806Article

Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblastsSANTEN, R. J; MARTEL, J; HOAGLAND, M et al.Breast cancer research and treatment. 1998, Vol 49, pp S93-S99, issn 0167-6806, SUP1Conference Paper

Aromatase inhibitor development for treatment of breast cancerMASAMURA, S; ADLERCREUTZ, H; HARVEY, H et al.Breast cancer research and treatment. 1995, Vol 33, Num 1, pp 19-26, issn 0167-6806Conference Paper